Real-world data for efficient health technology assessment

The new discipline of ‘real-world data science’ has emerged over recent years. Expert practitioners in this embryonic field are finding their feet, not just in terms of role and remit, but also with regards to which questions they can answer and the methods they can bring to bear [1]. But why are pharmaceutical companies employing real-world data scientists and seeking real-world data opportunities on a scale not previously seen? The last two decades saw a similar explosion in organisations with specialist expertise in the delivery of randomised controlled trials (RCTs) and pharmacovigilance to the standards of licencing authorities that include the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pOyRly
via IFTTT